Document Detail


Effects of sumatriptan on coronary flow and left ventricular function in the isolated perfused guinea pig heart.
MedLine Citation:
PMID:  9733357     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of the 5-HT1B/D receptor agonist, sumatriptan, on coronary flow (CF) and left ventricular function in the isolated perfused guinea pig heart were investigated in the presence and absence of coronary endothelial dysfunction induced by nitric oxide (NO) synthase inhibition with Nomega-nitro-L-arginine methyl ester (L-NAME; 10 microM). Hearts were perfused under constant pressure (80 cm H2O) with oxygenated (95% O2/5% CO2) Krebs bicarbonate buffer (pH 7.4) and were driven at 4 Hz. In the absence of L-NAME (n=37), sumatriptan (0.1-32 microM) failed statistically significantly to affect left ventricular developed pressure (LVDP; maximal change, -8.1+/-1.8%; NS vs. vehicle), left ventricular end-diastolic pressure (LVEDP; +10.4+/-9.8%, NS), or CF (-12.2+/-1.4%; NS compared with vehicle). L-NAME per se significantly reduced coronary flow (CF; -26.3+/-2.9%; p < 0.001), thereby increasing coronary vascular tone, and decreased LVDP (-17.1+/-1.8%; p < 0.01). In hearts perfused with L-NAME (10 microM; n=61), sumatriptan (0.1-32 microM) still failed significantly to affect CF (maximal change, 0.2+/-5.7%, NS) but concentration-dependently increased LVEDP [maximal increase, 89.0+/-30.3%; p < 0.05; geometric mean EC50 3.6 (2.9-5.7) microM], which was not prevented by the 5-HT1B/D receptor antagonist, GR 127935 (0.1 microM; maximal increase, 51.8+/-11.1%; n=48, NS compared with sumatriptan alone). In conclusion, sumatriptan failed significantly to affect CF even in the presence of endothelial dysfunction. LV function similarly remained unaffected in normal hearts, but sumatriptan produced diastolic contracture in the presence of coronary endothelial dysfunction by a mechanism apparently not involving 5-HT1B/D receptors. Collectively the data indicate that 5-HT1B/D receptor expression or effector coupling or both are absent or low in the guinea pig heart, because no detectable functional responses were observed.
Authors:
B Le Grand; B Vié; G W John
Related Documents :
3591167 - Haemodynamic and thermographic signs of intramyocardial venous outflow redistribution i...
1452937 - Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary ad...
8853157 - Comparison of passive and active perfusion catheters: an in vitro study in a pulsatile ...
18503137 - Influence of xantinole nicotinic acid on cutaneous microcirculation in patients with co...
2277407 - Treatment of canine acute pulmonary embolic shock--effects of isoproterenol and norepin...
18984777 - Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with typ...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  32     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-11-23     Completed Date:  1998-11-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  435-42     Citation Subset:  IM    
Affiliation:
Centre de Recherche Pierre Fabre, Division of Cardiovascular Diseases, Castres, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Coronary Circulation / drug effects*
Diastole / drug effects
Dihydroergotamine / pharmacology
Endothelium, Vascular / physiology
Guinea Pigs
NG-Nitroarginine Methyl Ester / pharmacology
Oxadiazoles / pharmacology
Oxazoles / pharmacology
Oxazolidinones*
Perfusion
Piperazines / pharmacology
Rabbits
Receptor, Serotonin, 5-HT1B
Receptor, Serotonin, 5-HT1D
Receptors, Serotonin / drug effects,  physiology
Serotonin Agonists / pharmacology*
Sumatriptan / pharmacology*
Tryptamines
Ventricular Function, Left / drug effects*
Chemical
Reg. No./Substance:
0/Oxadiazoles; 0/Oxazoles; 0/Oxazolidinones; 0/Piperazines; 0/Receptor, Serotonin, 5-HT1B; 0/Receptor, Serotonin, 5-HT1D; 0/Receptors, Serotonin; 0/Serotonin Agonists; 0/Tryptamines; 103628-46-2/Sumatriptan; 139264-17-8/zolmitriptan; 148672-13-3/GR 127935; 50903-99-6/NG-Nitroarginine Methyl Ester; 511-12-6/Dihydroergotamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol,...
Next Document:  Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury.